Have a Good Trip Benefit Show to Celebrate MAPS and Psychedelic Medicine

3 years ago

The Flaming Lips, Eric Andre, and Reggie Watts to headline benefit show on Thursday, June 22, at the Mission Ballroom…

PDS Biotech Completes Enrollment in Immune Checkpoint Inhibitor Naïve Arm of VERSATILE-002 Phase 2 Clinical Trial in Advanced HPV16 Positive Head and Neck Cancer

3 years ago

Company plans to initiate VERSATILE-003 Phase 3 clinical trial in late 2023FLORHAM PARK, N.J., May 18, 2023 (GLOBE NEWSWIRE) --…

Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors

3 years ago

BELGRADE, Mont., May 18, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…

New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes

3 years ago

Daxor’s BVA Technology Shown to Provide Unique and Individualized Data for Patient Management Oak Ridge, TN, May 18, 2023 (GLOBE…

Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference

3 years ago

TORONTO, May 18, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device…

HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention

3 years ago

TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools…

iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award

3 years ago

Company presented portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competition, focused on improving health…

Smart for Life Announces $1.58 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

3 years ago

MIAMI, May 18, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a…

Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer

3 years ago

Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapyMALVERN, Pa., May 18, 2023 (GLOBE NEWSWIRE)…

Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer

3 years ago

Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer Arun Balakumaran M.D., Ph.D, appointed Chief Medical Officer of Replay…